Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic dextrose versus triamcinolone injection for chronic knee osteoarthritis pain
IRCT20190325043107N32Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing Intra-articular dextrose with Intra-articular triamcinolone (2 arms). Primary endpoint: Pain. Started May 2023; status: completed.
02
Drugs
dextrosetriamcinolone
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20190325043107N32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N32.